"These 15 drugs, together with the 10 drugs that Medicare already negotiated, represent about a third of Medicare Part D spending ... HHS Secretary Xavier Becerra said during a call with reporters ...

As part of the Inflation Reduction ... important drugs for seniors,” said Xavier Becerra, HHS Secretary. “Today’s announcement is pivotal—the Inflation Reduction Act is lowering prices for people on ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

The Centers for Medicare and Medicaid Services (CMS) on Friday announced 15 additional Medicare Part D drugs selected ... drugs for seniors,” said Xavier Becerra, the secretary of the U.S ...

Health and Human Services Secretary Xavier Becerra called the announcement ... The drugs that are chosen represent the highest total Medicare Part B and D spending. “The 15 drugs selected ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

this effort addresses over a third of total Medicare Part D prescription drug costs. "Last year we proved that negotiating for lower drug prices works,” said HHS Secretary Xavier Becerra.

Drugs to treat cancer and type 2 diabetes are among those selected by CMS for the second cycle of Medicare Part D price negotiations ... HHS Secretary Xavier Becerra said in a press release.